Nyxoah S.A. (NASDAQ:NYXH) Expected to Post Earnings of -$0.32 Per Share

Equities research analysts expect Nyxoah S.A. (NASDAQ:NYXHGet Rating) to post ($0.32) earnings per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Nyxoah’s earnings, with the highest EPS estimate coming in at ($0.29) and the lowest estimate coming in at ($0.34). Nyxoah reported earnings of ($0.38) per share in the same quarter last year, which suggests a positive year-over-year growth rate of 15.8%. The firm is scheduled to report its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Nyxoah will report full year earnings of ($1.31) per share for the current financial year, with EPS estimates ranging from ($1.47) to ($1.16). For the next financial year, analysts anticipate that the firm will report earnings of ($1.85) per share, with EPS estimates ranging from ($2.40) to ($1.45). Zacks’ EPS averages are an average based on a survey of research analysts that cover Nyxoah.

NYXH has been the subject of several research analyst reports. Zacks Investment Research lowered Nyxoah from a “buy” rating to a “hold” rating in a report on Friday, April 1st. Oppenheimer assumed coverage on Nyxoah in a report on Wednesday, April 20th. They issued an “outperform” rating and a $30.00 price objective for the company. Piper Sandler lowered their target price on Nyxoah from $40.00 to $30.00 in a report on Friday, March 25th. Finally, Wolfe Research assumed coverage on Nyxoah in a report on Tuesday, April 5th. They set a “market perform” rating and a $21.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Nyxoah has a consensus rating of “Buy” and an average price target of $31.33.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Credit Suisse AG acquired a new stake in Nyxoah in the third quarter worth approximately $221,000. Jane Street Group LLC acquired a new stake in shares of Nyxoah during the 3rd quarter valued at $228,000. Evolutionary Tree Capital Management LLC lifted its position in shares of Nyxoah by 62.2% during the 4th quarter. Evolutionary Tree Capital Management LLC now owns 62,445 shares of the company’s stock valued at $1,436,000 after acquiring an additional 23,955 shares during the last quarter. Rossmore Private Capital lifted its position in shares of Nyxoah by 29.7% during the 4th quarter. Rossmore Private Capital now owns 117,940 shares of the company’s stock valued at $2,494,000 after acquiring an additional 27,000 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of Nyxoah during the 4th quarter valued at $2,895,000. Hedge funds and other institutional investors own 10.76% of the company’s stock.

Shares of NASDAQ:NYXH traded down $0.29 during trading on Friday, hitting $13.41. The company’s stock had a trading volume of 6,126 shares, compared to its average volume of 5,212. The company has a current ratio of 10.41, a quick ratio of 10.38 and a debt-to-equity ratio of 0.07. Nyxoah has a fifty-two week low of $12.81 and a fifty-two week high of $37.00. The stock’s 50-day moving average price is $17.34 and its two-hundred day moving average price is $19.63.

About Nyxoah (Get Rating)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Further Reading

Get a free copy of the Zacks research report on Nyxoah (NYXH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nyxoah (NASDAQ:NYXH)

Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.